GeneDx beat Wall Street's revenue and adjusted earnings expectations for the first quarter of 2025. Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. GeneDx reported Q1 revenue of $87.1 million, up 42% year over year.
Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, beating the consensus of $10.07. Humana sales increased from $29.6 billion to $32.11 billion, slightly missing the consensus of $32.22 billion. The revenue was driven by higher per-member Medicare and state-based contract premiums. The Medicare increase was primarily driven by an increased direct subsidy due to the Inflation Reduction Act (IRA) and membership growth in the company’s stand
When Meta (META) reports its 2025 first-quarter earnings after the market closes Wednesday, Wall Street will watch closely for signals on advertising resilience, genAI monetization, and fiscal discipline amid geopolitical headwinds, antitrust lawsuits, and general economic uncertainty.
OK